Sherbrooke Archives - Pediatric Research Foundation
Make a donation

THE CONTEXT Epilepsy is the most common chronic neurological condition in the world, affecting approximately 65 million people, including nearly 300,000 in Canada and 120,000 in Quebec. It usually manifests early in life: up to 85% of cases are diagnosed before adulthood. In children, epilepsy leads to chronic school absenteeism caused by seizures, medication side […]

Principal investigator

  • Dr. Alexander Weil, Department of Pediatric Neurosurgery, CHU Sainte-Justine
  • Prof. Sara Larivière, Department of Neuroscience, CHU de Sherbrooke

THE CONTEXT Developmental coordination disorder (DCD), also known as “dyspraxia,” is a neurodevelopmental condition that affects 5 to 6% of school-aged children and impacts motor performance and social participation. Young people with DCD have difficulty learning and performing motor skills and require more support and practice than their peers to carry out daily and physical […]

Principal investigator

  • Prof Emmanuelle Jasmin, CHU de Sherbrooke

Neurodevelopment and mental health

PROJECT CONTEXT Premenstrual Dysphoric Disorder (PMDD) is a severe mood disorder that appears during the luteal phase of the menstrual cycle, affecting approximately 1.2 to 6.4% of women. It manifests as emotional instability, depressed mood, anxiety and irritability, leading to significant distress. This disorder affects between 20,000 and 90,000 young girls and women in Canada. […]

Principal investigator

  • Pr Hugo Théôret, Centre de recherche CHU Sainte -Justine
  • Pr Jean-François Lepage, Centre de recherche CHU de Sherbrooke

Neurodevelopment and mental health

The research project, based on close collaboration between researchers at the Université de Sherbrooke and partners at CISSS-de-la-Montérégie-Centre, aims to document the effects of the HORIZON program, a nature and adventure-based intervention developed at CISSS-de-la-Montérégie-Centre. The program aims to better meet the needs of at-risk youth who do not respond well to traditional therapy. Nature […]

Principal investigator

  • Fabienne Lagueux, Ph.D. Chercheure principale, Université de Sherbrooke Faculté des lettres et sciences humaines (Psychologie de l’enfance et adolescence)

Neurodevelopment and mental health

Biomarkers are indicators of change that measure transformations in a person’s metabolism. They are used to monitor and predict the health status of an individual or population so that an appropriate therapeutic intervention can be planned.Cytomegalovirus (CMV) is the most common cause of congenital infections worldwide. This infection has an estimated annual incidence of between […]

Principal investigator

  • Pr Christiane Auray-Blais, Professor, Faculty of Medicine and Health Sciences FMSS Department of Pediatrics, Université de Sherbrooke
  • Pr Michel Boutin, Department of pediatry, Sherbrooke

Perinatal, neonatal and obstetrics

Currently, the method for diagnosis and follow-up of pulmonary hypertension is echocardiography. Unfortunately, this examination requires significant technical skill, a cumbersome device, and patient manipulation. It is not uncommon for the newborn’s hypertension to worsen from the manipulations required to perform the examination. The purpose of this project is to evaluate the accuracy of pulmonary […]

Principal investigator

  • Dr Etienne Fortin, Professor, Faculty of Medicine and Health Sciences, FMSS Department of Pediatrics, Université de Sherbrooke

Metabolic and cardiovascular health

Sphingolipidoses include Gaucher’s disease, Krabbe’s disease, Fabry’s disease, Niemann-Pick (types A/B/C), metachromatic leukodystrophy, GM1 and GM2 gangliosidosis, Sandhoff disease and Farber disease.

Principal investigator

  • Pr Christiane Auray-Blais, Professor, Faculty of Medicine and Health Sciences FMSS Department of Pediatrics, Université de Sherbrooke

Metabolic and cardiovascular health

Congenital heart defects affect >1 in 100 children (60 times more common than cancer). They increase the risk of hospitalization by 20 times and are responsible for 4% of all hospital admissions in children.

Principal investigator

  • Dr Frederic Dallaire, Faculty of Medicine and Health Sciences FMSS Department of Pediatrics, Université de Sherbrooke

Metabolic and cardiovascular health

On a global scale, 5%–10% of pregnancies are complicated by hypertensive disorders of pregnancy (HDP), which can lead to serious maternal, fetal, and neonatal complications. Many of these women have pre-existing hypertension (<20 weeks of pregnancy) or hypertension postpartum that persists for more than 3 months. It has also been shown that women with a self-managed postpartum HDP are at high risk of developing chronic hypertension and cardiovascular complications later.

Principal investigator

  • Dr. Anne-Marie Côté

Perinatal, neonatal and obstetrics

Accountability

-

While problematic eating attitudes and behaviours can surface during childhood and have extremely harmful effects over the long term, there have been no large-scale trials with enough participants to monitor children over a long period of time in order to identify and understand the psychosocial factors associated with the development of problematic eating attitudes and behaviours.

Principal investigator

  • Professor Isabelle Thibault, PhD in Clinical Sciences, Professor at the Faculty of Education and Psychoeducation, Université de Sherbrooke Research Centre

Metabolic and cardiovascular health Neurodevelopment and mental health